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ARTICLE
UBXN3B positively regulates STING-mediated
antiviral immune responses
Long Yang1,2, Leilei Wang1,3, Harshada Ketkar1, Jinzhu Ma1,4, Guang Yang5, Shuang Cui6, Tingting Geng 1,
Dana G. Mordue1, Toyoshi Fujimoto7, Gong Cheng8, Fuping You6, Rongtuan Lin2,
Erol Fikrig9,10 & Penghua Wang1
The ubiquitin regulatory X domain-containing proteins (UBXNs) are likely involved in diverse
biological processes. Their physiological functions, however, remain largely unknown. Here
we present physiological evidence that UBXN3B positively regulates stimulator-of-interferon
genes (STING) signaling. We employ a tamoxifen-inducible Cre-LoxP approach to generate
systemic Ubxn3b knockout in adult mice as the Ubxn3b-null mutation is embryonically lethal.
Ubxn3b−/−, like Sting−/− mice, are highly susceptible to lethal herpes simplex virus 1 (HSV-1)
and vesicular stomatitis virus (VSV) infection, which is correlated with deficient immune
responses when compared to Ubxn3b+/+ littermates. HSV-1 and STING agonist-induced
immune responses are also reduced in several mouse and human Ubxn3b−/− primary cells.
Mechanistic studies demonstrate that UBXN3B interacts with both STING and its E3 ligase
TRIM56, and facilitates STING ubiquitination, dimerization, trafficking, and consequent
recruitment and phosphorylation of TBK1. These results provide physiological evidence that
links the UBXN family with antiviral immune responses.
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The mammalian innate immune system detects invadingpathogens via several families of pattern recognitionreceptors, one of which the cyclic GMP-AMP synthase
senses cytosolic DNA1 and synthesizes cGAMP2,3. cGAMP serves
as a second messenger which binds an endoplasmic reticulum
(ER) membrane adaptor, stimulator-of-interferon genes (STING),
to trigger antiviral type I interferon (IFN-I) and inflammatory
immune responses4–6. STING undergoes lysine K63-linked
polyubiquitination mediated by E3 ligase tripartite motif con-
taining 32 (TRIM32) and TRIM567,8, dimerizes7, and trafficks
out of the ER to perinuclear vesicles6,9,10 where it recruits and
activates the kinase TANK-binding kinase 1 (TBK1) and inhibitor
of nuclear factor κB kinase5,11, and in turn innate immune
responses. STING could also transmit signals from other DNA
sensors such as DNA-dependent activator of IFN regulatory
factors (IRFs), DEAD-Box helicase 41, DNA-dependent protein
kinase, and IFN-γ-inducible protein 16; however, their function
in IFN-I response is still controversial12. Being such a central
adaptor in the DNA sensing pathway, STING signaling is
stringently regulated by post-translational modifications. TBK1-
mediated phosphorylation of STING provides a “licensing”
mechanism for TBK1 to phosphorylate IRF3 and induction of
IFN-I13, while nucleotide-binding oligomerization domain
receptor X1 sequesters STING to negatively regulate its signal-
ing14. K63-linked polyubiquitination by TRIM32, TRIM56, and
mitochondrial E3 ubiquitin protein ligase 1 (MUL1), K27 poly-
ubiquitination by ER-resident E3 ligase complex autocrine
motility factor receptor (AMFR)–insulin-induced gene 1
(INSIG1) promotes STING signaling7,8,15, while K48-linked
polyubiquitination of STING by E3 ligases Ring finger protein
5 and TRIM30α dampens its signaling by targeting it for
proteasomal degradation16,17. Obviously, regulation of STING by
ubiquitination is very complex and the in vivo physiological
relevance of different types of ubiquitination and E3 ligases
remains elusive.
The ubiquitin regulatory X (UBX) domain shares weak
homology with ubiquitin at the protein level and adopts the same
three-dimensional-fold as ubiquitin18. One of the best understood
UBXN proteins, p47, is a cofactor of the AAA ATPase (ATPase
associated with various cellular activities), p9719. p97 is highly
conserved across species and involved in diverse cellular pro-
cesses, including ubiquitin-dependent protein degradation, vesicle
fusion, and cell cycle18. Several UBXN proteins have been
recently shown to bind p97 and a large number of E3 ubiquitin
ligases20, suggesting a potential role for UBXNs in regulation of
global protein turnover and cellular signaling. However, the
molecular function of the majority of UBXN proteins is largely
unknown. Here we perform a family-based screening to identify a
UBXN that could modulate STING-dependent signaling. Indeed,
by utilizing dual luciferase reporter system, we identify that
UBXN3B is a positive regulator of STING and that UBXN3B
complexes with STING and TRIM56 to potentiate STING-
dependent innate immune responses.
Results
UBXN3B regulates STING-dependent IFN-I induction. We
performed an IFN-stimulated response element (ISRE) reporter
activation screening in human embryonic kidney 293 cells
transformed with T antigen of SV40 (HEK293T) cells for UBXNs
that enhanced a STING-mediated IFN response. Transfection
with HA-STING plasmid and vector induced ISRE activity by
~150-fold relative to vector alone (Supplementary Fig. 1a).
Interestingly, among all the UBXNs tested, UBXN3B most sig-
nificantly potentiated a STING-induced IFN-I response, which
was ~5-fold higher than STING alone (Supplementary Fig. 1a).
Overexpression of UBXN3B alone did not induce ISRE sig-
nificantly (Supplementary Fig. 1b–d), indicating that UBXN3B is
a positive regulator of STING-dependent signaling. To validate
the screening results, we used cGAMP, a second messenger that
binds and stimulates STING signaling1,21. cGAMP was used to
prime HEK293T cells stably expressing FLAG-STING (desig-
nated HEK293T-STING cell line) following transfection with a
UBXN3B expression plasmid. We found that UBXN3B syner-
gized with cGAMP to induce an IFN-I response in a dose-
dependent manner (Supplementary Fig. 1b and 1c). To confirm
that the enhancing effect on STING signaling was specific to
UBXN3B, we included two UBXN members, UBXN3A which is
the closest sibling of UBXN3B and UBXN9 which is more dis-
similar from UBXN3B, in terms of domain structure20. Indeed,
only UBXN3B, but not UBXN3A or UBXN9, enhanced the
cGAMP-induced IFN-I response (Supplementary Fig. 1d). In
addition, we tested if UBXN3B has a modulatory effect on other
important antiviral signaling pathways. The results demonstrate
that UBXN3B failed to synergize with retinoic acid-inducible gene
I (RIG-I)-like receptor (RLR)-mediated and Toll-like receptor
(TLR)-mediated IFN-I induction (Supplementary Fig. 2). These
data suggest that UBXN3B specifically targets STING signaling.
UBXN3B is critical for anti-DNA virus immune responses.
UBXN3B, also known as Fas-associated factor 2 and UBXD8,
might play a role in regulating lipid metabolism22–24. However,
its physiological function remains largely unclear. We therefore
attempted to generate general Ubxn3b−/− mice using the
CRISPR-Cas9 technology and unfortunately failed, suggesting
that Ubxn3b deletion is embryonically lethal, consistent with a
recent publication24. We therefore planned to generate an
inducible conditional knockout strain so as to systemically ablate
UBXN3B gene expression. We obtained Ubxn3bflox/flox (exon 1,
homologous recombination) from our collaborator24 and crossed
it with a tamoxifen-inducible Cre mouse line25,26, to generate a
Cre+/−Ubxn3bflox/flox mouse. The tamoxifen-inducible Cre
model has been successfully applied to many gene deletions
including essential genes25. Indeed, Ubxn3b protein expression
was abolished in various tissues of tamoxifen-treated Cre
+/−Ubxn3bflox/flox mice (Fig. 1a). However, no discernible
developmental defects or behavioral abnormality were observed
in these mice. We then infected tamoxifen-pretreated Cre+/−
Ubxn3bflox/flox (referred to as Ubxn3b−/− for convenience
throughout the manuscript) or untreated Cre+ Ubxn3bflox/flox
(referred to as Ubxn3b+/+) littermates with a DNA virus, herpes
simplex virus 1 (HSV-1), which effectively induces STING sig-
naling. To exclude any potential side effects of tamoxifen on
HSV-1 pathogenesis and/or antiviral immunity, we included
tamoxifen-treated Cre+/− and Ubxn3bflox/flox littermates as con-
trols. As shown in Fig.1b, Ubxn3b−/− mice (N= 8) died of HSV-
1 infection earlier than Ubxn3b+/+ mice (N= 8) and the other
control mice (N= 9). The overall survival rate of Ubxn3b−/−
mice was also much lower (P < 0.01, log-rank test). In addition, all
infected Ubxn3b−/− mice developed severe neurological symp-
toms, as well as hunched posture, decreased movement, and
labored breathing on day 3 after infection. These symptoms were
completely absent from Ubxn3b+/+ animals (Supplementary
Movie 1). Compared to Sting−/− mice (N= 8), Ubxn3b−/− mice
(N= 9) were a bit less sensitive to HSV-1 infection (Fig. 1c). In
agreement with the survival data, the serum IFN-I abundance was
markedly decreased at 4 and 8 h after HSV-1 inoculation in
Ubxn3b−/− (N= 6) compared to Ubxn3b+/+ (N= 10) mice
(non-parametric Mann–Whitney test, P < 0.05), demonstrating
that UBXN3B is critical for HSV-1-induced IFN response
(Fig. 1d). In agreement with this, the mRNA levels of Ifnb1, Tnfa,
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and Ifit1 (an IFN-I-induced antiviral effector) in leukocytes of
Ubxn3b−/− mice were also lower than those in Ubxn3b+/+ lit-
termates (N= 5 each genotype, P < 0.05, non-parametric
Mann–Whitney test) (Supplementary Fig. 3). Given that HSV-1
can penetrate the brain and elicit fatal encephalitis in mice, we
then quantified HSV-1 titers in the brain by plaque-forming
assay. Ubxn3b−/− mice had a significantly increased number of
viral particles compared to Ubxn3b+/+ mice on day 3 after
infection (N= 5 each genotype, P < 0.01, non-parametric
Mann–Whitney test) (Fig. 1e).
We next asked if the antiviral function of UBXN3B was cell-
type specific. We isolated bone marrow cells from Cre+/−
Ubxn3bflox/flox mice pretreated without (Ubxn3b+/+) or with
tamoxifen (Ubxn3b−/−) and differentiated them into macro-
phages (bone marrow-derived macrophage (BMDMs)) with L929
cell-conditioned medium, conventional dendritic cells (cDCs)
with granulocyte–macrophage colony-stimulating factor (GM-
CSF) and plasmacytoid DC (pDCs) with Flt3L. Induction of IFN-
I protein by HSV-1, STING-stimulating immunostimulatory
DNA (ISD) and cGAMP was remarkably compromised in
knockout cells (Fig. 2a). Correspondingly, induction of Oas1a
protein, an IFN-stimulated gene (ISG), was also impaired in
knockout cDC cells (Fig. 2b). The mRNA levels of Ifnb1 and Tnfa
were decreased in Ubxn3b−/− cells at 6 h after infection, which
was accompanied by increased viral load (Fig. 2c, d). The above-
mentioned immune cells are not very permissive to HSV-1
Infection. We next isolated mouse embryonic fibroblasts (MEFs),
which are highly permissive to HSV-1 in contrast to the
above-mentioned immune cells we induced in vitro, from
untreated Cre+/− Ubxn3bflox/flox E14 embryos and induced
Ubxn3b deletion with 4-hydroxyl tamoxifen in vitro.
Ubxn3b protein expression was almost completely depleted after
4-hydroxyl tamoxifen treatment in Cre+/− Ubxn3bflox/flox
(Ubxn3b−/−) cells (Fig. 2e). In agreement with the aforemen-
tioned results, the viral titers produced by Ubxn3b−/− cells were
higher than Ubxn3b+/+ (Fig. 2f). Ifnb1 and its ISG mRNA
levels induced by HSV-1 were consistently down-regulated in
Ubxn3b−/− cells (Fig. 2g).
The UBXN3B protein is evolutionarily conserved, with 97%
identity between human and rodent. We then asked if its antiviral
function is also evolutionarily conserved. We employed the
CRISPR-Cas9 technology to generate UBXN3B−/− in H1975 cell,
a human lung epithelial cell line (Supplementary Fig. 4a).
Consistent with the results from mouse cells, IFNB1 induction
by ISD was much lower in UBXN3B−/− cells than wild type (WT)
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Fig. 1 UBXN3B is critical for IFN-I induction by and control of HSV-1 infection in vivo. a Immunoblots showing Ubxn3b knockout efficiency in various tissues
without/with tamoxifen (TMX) treatment in Cre+/− Ubxn3bflox/flox mice. Tubulin is a housekeeping protein control. b, c The survival curves of tamoxifen
(TMX)-treated Ubxn3bflox/flox, TMX-treated Cre+/−, mock-treated Cre+/− Ubxn3bflox/flox (designated Ubxn3b+/+) and TMX-treated Cre+/− Ubxn3bflox/
flox (designated Ubxn3b−/−) littermate and Sting−/− mice challenged with 1 × 107 plaque-forming units (PFU) per mouse of HSV-1 i.v. N= 8–9 mice/
genotype. ***P < 0.001 (log-rank test). d The serum IFN-I concentrations (mean ± s.e.m) of mice challenged with 2 × 106 PFU per mouse of HSV-1 i.v. **P <
0.01; *P < 0.05 (non-parametric Mann–Whitney test), N= 10 (Ubxn3b+/+) or N= 6 (Ubxn3b−/−). e The viral titers (mean ± s.e.m) in the brain on day 3
after infection (PFU per gram tissue). **P < 0.01 (non-parametric Mann–Whitney test), N= 5 mice per genotype. The data are pooled from two
independent experiments
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(polyIC)-induced IFNB1 expression was not significantly
impaired (Supplementary Fig. 4b). The HSV-1 titers (Supplemen-
tary Fig. 4c) and intracellular HSV-1 protein levels (Supplemen-
tary Fig. 4d) were very much increased in UBXN3B−/− cells
compared to WT cells, suggesting a critical antiviral role for
UBXN3B. The immune responses to HSV-1 including IFN-I
(IFNB1) and inflammatory response (TNFA) were reduced in the
absence of UBXN3B expression (Supplementary Fig. 4e). To
extend this further, we next examined the UBXN3B antiviral
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physiologically related to vertical transmission of HSV-1; (2) can
be passaged in vitro for up to 12–15 generations27, which allows
us to knockout the genes of interest with CRISPR-Cas9 and
examine their functions; and (3) can be obtained in a large
quantity. In parallel, we included STING−/− as a positive control.
As shown in Fig. 2h, STING and UBXN3B protein expression was
depleted in knockout cells. Both STING−/− and UBXN3B−/− cells
were more permissive to HSV-1 infection than WT (Fig. 2i); the
Fig. 2 UBXN3B is critical for STING-dependent IFN-I induction in mouse primary cells. a ELISA of IFN-α in the cell culture supernatants of (Ubxn3b+/+,
Ubxn3b−/−) bone marrow-derived macrophages (Mϕ), Flt3-induced pDCs, and GM-CSF-induced cDCs (pooled from five littermates) 20 h after the
indicated treatments. N= 3 per genotype. *P < 0.05 (unpaired Student’s t test). b Immunoblots of an interferon-stimulated gene Oas1a, Sting, and Ubxn3b
expression in cDCs 20 h after the indicated treatments. Tubulin is a housekeeping protein control. qPCR analysis of (c) Ifnb1 and Tnfa mRNA expression
and d cellular HSV-1 genome loads in cDCs infected with HSV-1 (MOI= 10) for the indicated time. e Immunoblots showing Ubxn3b and housekeeping
Gapdh protein expression in mock (Ubxn3b+/+) or 4-hydroxyl tamoxifen-treated Cre+/− Ubxn3bflox/flox (Ubxn3b−/−) MEFs. f Viral titers (plaque-forming
units/ml) in the supernatant of MEFs infected with HSV-1 (MOI= 0.1). N= 3 per genotype per time point. *P < 0.05; **P < 0.01 (unpaired Student’s t test).
g qPCR analysis of selected immune gene mRNA expression in MEFs infected with HSV-1 as in g. h The immunoblots show knockout efficacy of STING and
UBXN3B by CRISPR-Cas9 in human primary trophoblasts. Actin is a housekeeping protein control. i Fluorescent microscopic images of human primary
trophoblasts infected with HSV-1-GFP (MOI= 0.3) for 18 h. Objective, ×5. Scale bar, 10 µm. j qPCR analysis of Ifnb1 mRNA expression in human primary
trophoblasts infected with HSV-1-GFP for the indicated time. Bars/data points: mean ± s.e.m. Two biological replicates were pooled for qPCR (N= 2 per
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Fig. 3 UBXN3B is critical for type I IFN responses to SeV and VSV, but not EMCV infection. a The survival curves of Ubx3b−/− (N= 6) and Ubxn3b−/− (N
= 7) mice infected with 1 × 107 PFU of VSV i.v. The results are pooled from two experiments. *P < 0.05 (log-rank test). b, c qPCR analysis of Ifnb1
expression in cDCs infected with b VSV (MOI= 5) or c SeV (200 hemagglutination units per 105 cells). d ELISA of IFN-α in the cell culture supernatants of
cDCs infected with SeV and VSV as in b, c. N= 3 per genotype per time point. *P < 0.05 (unpaired Student’s t test). e The survival curves of Ubx3b+/+ (N
= 7) and Ubxn3b−/− (N= 8) mice infected with 200 PFU of EMCV i.p. P= 0.53 (log-rank test). The results are pooled from two experiments. f qPCR
analysis of Ifnb1 expression in cDCs infected with EMCV (MOI= 5) for the indicated time. Bars/data points: mean ± s.e.m. Two biological replicates were
pooled for qPCR (N= 2 per genotype per time point). *P < 0.05 (unpaired Student’s t test). The results are representative of two independent experiments
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IFNB1 mRNA expression was, however, much lower in knockout
cells (Fig. 2j). These results demonstrate that the STING-
regulating function of UBXN3B is evolutionarily conserved.
UBXN3B regulates immune responses to some RNA viruses.
STING signaling is not only essential for induction of immune
responses to DNA viruses but also important for antiviral
immunity to certain RNA viruses such as VSV and Sendai virus
(SeV). We then investigated the physiological role of UBXN3B
during RNA virus infection. Consistent with the phenotype of
Sting−/− infected with VSV5, Ubxn3b−/− mice (N= 6) were also
more susceptible to lethal VSV infection than its Ubxn3b+/+
littermates (N= 7 each genotype, P < 0.05, log-rank test) (Fig. 3a).
The Ifnb1 mRNA expression was modestly decreased in knockout
cDCs at 12 h after infection (Fig. 3b). Similarly the Ifnb1 tran-
scripts were also reduced in knockout cells infected with SeV
(Fig. 3c). Consistent with this, the IFN-α protein concentration in
the knockout cell supernatants was modestly lower than WT
(Fig. 3d). However, Ubxn3b was dispensable for the control of a
non-enveloped (+) single-stranded RNA virus, encephalomyo-
carditis virus (EMCV) infection in vivo (Fig. 3e), and for innate
immune responses in cDCs (Fig. 3f). This is also consistent with
the phenotype of Sting−/− mice5.
UBXN3B regulates STING signaling. All the aforementioned
in vivo and in vitro results clearly indicate an essential role of
UBXN3B in the STING signaling pathway. To see whether
UBXN3B also plays a role in other pathogen pattern recognition
receptors such as RLR and TLR signaling pathways, we examined
immune response induction in cDCs by several well-established
RLR/TLR agonists. The results show that Ifnb1 and Tnfa mRNA
upregulation by CpG DNA (TLR9), FLS-1 (Pam2CGDPKHPKSF,
TLR2/6), lipopolysaccharide (LPS, TLR4), high-molecular-weight
polyIC (TLR3, MDA5), and single-stranded poly-uridine (polyU,
TLR7) in Ubxn3b−/− was not significantly different from Ubxn3b
+/+ cDCs (Supplementary Fig. 5a–e). These data demonstrate
that UBXN3B is not essential for TLR/RLR-dependent signal-
ing28. We next asked if UBXN3B regulated the IFN-JAK-STAT
pathway, which induces expression of a large number of antiviral
effectors. As shown in Supplementary Fig. 5f, the Isg15 and Oas1a
mRNA expression levels were similar between Ubxn3b+/+ and
Ubxn3b−/− cDCs, suggesting that UBXN3B is dispensable for the
JAK-STAT signaling pathway. Furthermore, we observed that
Ubxn3b expression was induced by IFN-α in both cDCs and
MEFs, which was completely dependent on the IFN-I receptor
signaling (Supplementary Fig. 6). Intriguingly, we noted that
Ubxn3b was gradually and constantly upregulated throughout
IFN-α treatment (Supplementary Fig. 6a). These data suggest that
UBXN3B is an ISG.
We next explored the molecular mechanism by which
UBXN3B acts on STING-dependent signaling. Lysine (K) 63-
linked ubiquitination and dimerization of STING is a prerequisite
for STING trafficking out of the ER to perinuclear vesicles where
it recruits the antiviral kinase TBK1 to induce IFN-I7,9,10,29.
STING is then phosphorylated and degraded via autophagy29 and
proteasomes30. UBXN proteins are likely involved in regulation of
E3 ubiquitin ligases20. We first asked whether UBXN3B played a
role in STING dimerization, trafficking, and phosphorylation.
Indeed, STING dimerization took places 8 h after HSV-1
infection in Ubxn3b+/+ MEFs, but this was obviously reduced
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Fig. 4 UBXN3B regulates STING dimerization, phosphorylation, and degradation. a Immunoblots showing Sting dimerization in untreated (Ubxn3b+/+) and
4-hydroxyl tamoxifen-induced Cre+/− Ubxn3bflox/flox (Ubxn3b−/−) primary MEFs. The cells were infected without (mock) or with HSV-1 (MOI= 0.5) for
8 h. b Immunoblotting analysis of the whole-cell lysates of bone marrow-derived cDCs infected with HSV-1 (MOI= 5). Mono monomer, 2-ME
β-mercaptoethanol, a chemical compound that reduces disulfide bonds. c qPCR quantification of Ifnb1 and Tnfa mRNA induction in cDCs by HSV-1
(MOI= 5). Bars: mean ± s.e.m. Two biological replicates were pooled for qPCR (N= 2 per genotype per time point). *P < 0.05 (unpaired Student’s t test).
d–f Immunoblotting analysis of the whole-cell lysates of d MEFs infected with HSV-1 (MOI= 0.5), e MEFs transfected with ISD (8 µg/ml) in the absence
or presence of 40 µM of chloroquine (+CQ) and f trophoblasts transfected with cGAMP (8 µg/ml). In e, f, the arrows indicate phosphorylated STING with
long and short exposure. Actin, Tubulin (Tub), and GAPDH are housekeeping protein controls. g qPCR quantification of IFNB1 and TNFA mRNA induction in
trophoblasts transfected with cGAMP (8 µg/ml). In c, g, the bars are: mean ± s.e.m. Two biological replicates were pooled for qPCR (N= 2 per genotype
per time point). *P < 0.05 (unpaired Student’s t test). The results are representative of two to three independent experiments
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04759-8
6 NATURE COMMUNICATIONS |  (2018) 9:2329 | DOI: 10.1038/s41467-018-04759-8 | www.nature.com/naturecommunications
cDCs (Fig. 4b). Moreover, HSV-1-induced phosphorylation of
TBK1 and IRF3 was inhibited in Ubxn3b−/− cDCs (Fig. 4b).
Consequently, Ifnb1 and Tnfα mRNA transcripts were also
decreased in Ubxn3b−/− (Fig. 4c). STING is degraded after HSV-
1 infection in permissive cells like MEFs. We extended the HSV-1
infection and indeed observed overt Sting degradation in Ubxn3b
+/+ cells at 12 h and this was inhibited in knockout cells (Fig. 4d).
A similar result was noted in H1975 cells (Supplementary Fig. 7).
ISD also stimulated STING degradation, which was partially
blocked in Ubxn3b−/− (Fig. 4e). These data suggest that STING
translocation from the ER to perinuclear vesicles is influenced by
UBXN3B deficiency too. We investigated this in H1975 cells by
immunofluorescence microscopy. In unstimulated cells, STING
co-localized with an ER-resident protein calreticulin very well.
STING was localized to some punctate structures that were away
from calreticulin-stained ER 3 h after ISD stimulation in
WT cells, but remained co-localized with calreticulin in ISD-
treated UBXN3B−/− cells (Supplementary Fig. 8). Following
translocation, STING is phosphorylated and degraded partially by
autophagy. We did not readily detect phospho-Sting in ISD-
treated MEFs, likely because of its rapid degradation following
phosphorylation in these cells. We thus added chloroquine to
block autophagy-mediated Sting degradation in order to capture
phospho-Sting. Indeed, chloroquine treatment delayed Sting
degradation and Sting phosphorylation was observed at 4 h after
ISD treatment in Ubxn3b+/+ cells but clearly absent in Ubxn3b−/−
MEFs (Fig. 4e). Interestingly, STING phosphorylation was much
readily detected in human trophoblasts. Using a specific antibody
against only the phosphorylated human STING, we noted rapid
phosphorylation of STING at 4 h after cGAMP treatment. STING
phosphorylation was obviously reduced, so was TBK1; while
STING degradation was inhibited in UBXN3B−/− cells (Fig. 4f).
As a result, IFNB1 and TNFA mRNA upregulation by cGAMP
was repressed in UBXN3B−/− cells (Fig. 4g).
The aforementioned data clearly demonstrate that UBXN3B
regulates STING signaling and its downstream immune
responses. To test if UBXN3B directly participated in STING
signaling complex, we employed a co-immunoprecipitation assay
in HEK293T cells with simultaneous expression of FLAG-tagged
UBXNs and HA-tagged STING. UBXN3B but not its sibling
UBXN3A co-immunoprecipitated with STING (Fig. 5a), suggest-
ing that UBXN3B–STING binding is specific and that UBXN3B is
involved in STING signaling. By fluorescence microscopy, we
observed that UBXN3B co-localized with STING to the ER in
unstimulated cells (Mock), and partly translocated together with























































































































































































Fig. 5 UBXN3B interacts with STING and TRIM56. a Co-immunoprecipitation (co-IP) of STING with UBXN3B from HEK293 cells transfected with
FLAG-UBXNs and HA-STING plasmids using anti-FLAG magnetic beads, followed by immunoblotting (IB) with an anti-HA (STING) and FLAG (UBXN)
antibody. b Immunofluorescence staining of STING and UBXN3B in H1975 cells treated without (Mock) or with ISD (8 µg/ml) for 3 h. The cells were
stained with a mouse anti-human STING and rabbit anti-UBXN3B antibody followed by a secondary antibody conjugated with Alexa Fluor 594/488. The
nuclei were stained with DAPI. Objective, ×40. Scale bar, 200 µm. c A schematic diagram of UBXN3B functional domains. d Co-IP of STING with the
truncated forms of UBXN3B. The procedures are similar to b. e Co-IP of UBXN3B with TRIM from HEK293 cells transfected with FLAG-UBXN3B and Myc-
TRIM plasmids using anti-Myc magnetic beads, followed by IB with an anti-Myc (TRIM) and FLAG (UBXN3B) antibody. f Co-IP of TRIM56 with the
truncated forms of UBXN3B from HEK293 cells transfected with FLAG-UBXN3B truncates and Myc-TRIM56 plasmids using anti-FLAG magnetic beads,
followed by IB with an anti-Myc (TRIM56) and FLAG (UBXN truncates) antibody. GAPDH is a housekeeping protein control. WCE whole-cell extract. The
results are representative of two independent experiments
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further showed that the UAS domain of UBXN3B was required
for UBXN3B–STING interaction (Fig. 5c, d; Supplementary Fig. 9
a, b).
Ubiquitination of STING is essential for its downstream
signaling and induction of antiviral immune responses. Several
UBXNs including UBXN3B with the UBA-UBX domain are
putative adaptor molecules that interact with E3 ligases and their
substrates20. They likely also determine substrate specificity under
different physiological conditions. We hypothesized that
UBXN3B might serve as an adaptor that bridges STING and its
E3 ligase. Three E3 ligases TRIM32, TRIM56, and AMFR have
recently been shown to mediate STING ubiquitination during
viral infection7,8,15. In particular, TRIM56 mediates both covalent
and non-covalent ubiquitination of STING7. We first evaluated
the ability of each of the E3 ligases to activate STING-dependent
IFN-I responses. Results show that overexpression of TRIM56,
but not AMFR, dramatically activated and synergized with
cGAMP to induce STING-dependent IFN-I, while TRIM32
modestly activated and synergized with cGAMP to induce IFN-
I (Supplementary Fig. 10). We next determined whether TRIM56
or TRIM32 associated with the STING–UBXN3B complex.
UBXN3B co-immunoprecipitated with TRIM56 but not TRIM32
(Fig. 5e). The coil-coiled domain of UBXN3B mediated its
interaction with TRIM56 (Fig. 5f; Supplementary Fig. 9c). Very
recently, another E3 ligase MUL1 was shown to be essential for
STING ubiquitination on K224 and IRF3 activation31. We
performed co-immunoprecipitation with MUL1 and UBXN3B
overexpression in HEK293 cells to see if UBXN3B also regulated
MUL1–STING interaction. We however observed no interaction
between MUL1 and UBXN3B. These data suggest that UBXN3B
specifically regulates STING–TRIM56 interaction. Indeed, HSV-1
infection induced endogenous Sting binding to Trim56 and
Ubxn3b in MEFs (Fig. 6a). Furthermore, viral infection-induced
Sting–Trim56 binding was almost abrogated in Ubxn3b−/− cells
but was restored in UBXN3B-reconstituted knockout cells
(Fig. 6b). These data overall demonstrate that UBXN3B is critical
for HSV-1-induced STING–TRIM56 interaction. We next
examined the role of UBXN3B in TRIM56-mediated STING
ubiquitination. Overexpression of TRIM56 enhanced endogenous
K63-linked ubiquitination of STING in WT cells (HEK293T-
STING cell line), but this effect was reduced in UBXN3B−/− cells
(Fig. 6d) (UBXN3B−/− was generated on HEK293T-STING
background (see Fig. 6c). As previously described7, K150R
mutation decreased STING K63 ubiquitination by TRIM56
(Supplementary Fig. 11a). Trans-complementation of UBXN3B





































































































































Fig. 6 UBXN3B mediates STING interaction with and ubiquitination by TRIM56. a WT and Stinggt/gt MEFs were infected with or without HSV-1
(MOI= 0.5) for 8 h. Sting was immunoprecipitated (IP) from the MEF lysates using a rabbit anti-Sting antibody. The immunoblots indicate Sting
co-immunoprecipitation with Ubxn3b and Trim56 after viral infection. WCE whole-cell extract. bWT and Ubxn3b−/− MEFs were transfected with vector or
FLAG-UBXN3B plasmids by electroporation, and then infected with HSV-1 (MOI= 0.5) for 8 h. Sting IP was performed as in a. Rabbit IgG was used as a
negative control. c The immunoblots show knockout efficacy of UBXN3B in HEK293T-STING cell line. d WT and UBXN3B−/− cells (parent cell line is
HEK293T-FLAG-STING) were transfected with the indicated combinations of plasmids. FLAG-STING was immunoprecipitated (IP) with anti-FLAG
magnetic beads. The proteins in IP and WCE were immunoblotted by an anti-K63-linked polyubiquitin, anti-Myc (UBXN3B and TRIM56) and anti-FLAG
(STING) antibody, respectively. e Sting was precipitated with a rabbit anti-Sting antibody from cDCs infected without or with HSV-1 (MOI= 10) for 4 and
8 h. The Sting−/− cDCs were used as an IP control. The proteins in IP and WCE were immunoblotted with an anti-K63 and Sting antibody, respectively.
Tubulin and GAPDH are housekeeping controls. The results are representative of two independent experiments
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To validate the aforementioned overexpression results, we
examined endogenous K63 ubiquitination of Sting in cDCs.
HSV-1 infection induced K63 ubiquitination of Sting at 4 and 8 h
after infection in Ubxn3b+/+, but this was obviously impaired in
Ubxn3b−/− cDCs (Fig. 6e). We recapitulated this in primary
human trophoblasts treated with cGAMP (Supplementary
Fig. 11b). Of note, co-immunoprecipitation of STING with
TBK1 was observed in WT cells, but not in UBXN3B−/− cells,
after cGAMP stimulation (Supplementary Fig. 11b). These data
suggest that UBXN3B modulates TRIM56-mediated K63-linked
ubiquitination of STING and activation of TBK1.
Discussion
Being a central molecule of the anti-DNA virus immune signaling
pathway, STING is subjected to complex regulation by cellular
factors and also many viruses12. We here present physiological
and biochemical evidence that UBXN3B controls DNA virus
infection by regulating STING-mediated antiviral immune
responses. First, ectopic expression of UBXN3B potentiates spe-
cifically STING-dependent IFN-I induction. Second, Ubxn3b−/−
mice and cells are deficient in IFN-I induction by HSV-1, ISD,
and cGAMP that stimulate STING signaling. Third, Ubxn3b−/−
mice are highly susceptible to HSV-1 and VSV infection, but not
to EMCV infection, recapitulating the Sting−/− phenotypes.
Fourth, UBXN3B interacts with both STING and
TRIM56 simultaneously, and HSV-1-induced STING–TRIM56
interaction is compromised in UBXN3B−/− cells. Fifth, UBXN3B
deficiency leads to decreased K63 ubiquitination and dimerization
of STING, and consequent phosphorylation of TBK1 and IRF3.
STING translocation out of the ER to the ER–Golgi intermediate
compartment, followed by phosphorylation and degradation after
HSV-1/ISD/cGAMP stimulation, is also partly blocked in
UBXN3B−/− cells. Lastly, UBXN3B can be induced by IFN-I,
likely to form a positive feedback loop to stimulate antiviral
immune responses. All these observations strongly suggest that
UBXN3B directly regulate STING signaling. However, STING-
mediated immune responses are not completely abolished in
UBXN3B−/− cells and mice, suggesting that UBXN3B-
independent regulation of STING and IFN-I-inducing pathways
exist. Several E3 ligases that may not be directly relevant to
UBXN3B have been shown to positively regulate STING signal-
ing8,15,31. Moreover, in pDCs TLR9 contributes to induction of
the IFN-I responses by HSV-132,33, which however is not regu-
lated by UBXN3B.
The UBA-UBX-containing UBXN proteins may be adaptors
that bridge multiple E3 ligases and a variety of substrates20, and
likely essential for embryonic development. Indeed, by using
different genome editing technologies, we and collaborators
independently find that Ubxn3b-null mutation is embryonically
lethal24. In agreement with our findings, another UBA-UBX gene,
UBXN1, is also essential for embryonic development34. The genes
essential for embryonic/neonatal stages are generally believed to
be essential for adult stage too. For example Gpx4 and p53 is not
only essential for embryos/neonates but also for adult mice25,26.
Surprisingly, adult mice depleted of Ubxn3b survive and develop
as normally as WT mice. This interesting finding suggests that
some of the genes indispensable for embryonic development may
become non-essential at later stages of development. Our results
provide proof of principle for in-depth study of the physiological
functions of essential genes like UBXN3B in adult systemic
knockout mice.
Of note, Ubxn3b protein expression is still abundant and
ubiquitous in adult mice, suggesting that it plays different phy-
siological roles than that at the embryonic stage. Previous studies
demonstrated that UBXN3B regulated triglyceride synthesis and
lipid droplet turnover in vitro cell cultures22,23, and promoted
very low-density lipoprotein secretion out of hepatocytes in mice
fed with a high-fat diet24. More recently, UBXN3B was shown to
regulate de novo sterol biosynthesis by targeting the rate-limiting
enzyme of the mevalonate pathway-HMG-CoA reductase to
proteasomal degradation35. In the current study, we show that
under viral infection conditions, UBXN3B bridges the ER protein
STING and its cytoplasmic E3 ligase TRIM56 to initiate antiviral
immune responses. The multifaceted nature of UBXN3B is likely
attributable to its capability as an adaptor to interface different E3
ligases20 and substrates under different physiological conditions.
The involvement of an adaptor in an E3 ligase action could
greatly expand the substrate spectrum of the E3 ligase in response
to various physiological and environmental cues.
Following DNA virus infection, STING undergoes four forms
of polyubiquitination, K11-linked36, K27-linked15, K48-
linked16,17, and K63-linked7,8,31, resulting in contrasting effects
on STING-mediated immune signaling. Particularly, K27-linked
and K63-linked polyubiquitination activates STING. In agree-
ment with published data7,8, forced expression of K63-E3 ligases
TRIM32 and TRIM56 enhanced STING-dependent IFN-I
induction and significantly potentiated the cGAMP effects on
STING. However, overexpression of a K27-E3 ligase AMFR failed
to induce IFN-Is by itself or together with cGAMP, suggesting a
different mechanism of AMFR action than TRIM32 and TRIM56.
A similar phenomenon has been observed for TRAF3, a K63-E3
ligase critical for TLR-dependent and RLR-dependent IFN-I
induction37. It is not surprising that redundant K63-E3 ligases are
available for STING, since it is crucial for induction of anti-DNA
virus immunity. Indeed, recently another K63-E3 ligase MUL1
was shown to ubiquitinate the K224 of STING and specifically
regulate IRF3 activation, followed by STING phosphorylation and
degradation31. Our results demonstrate that UBXN3B regulates
TRIM56-mediated ubiquitination of STING. It binds STING via
the UAS domain and TRIM56 via the coiled-coil domain, likely
serving as an adaptor to bring STING to the vicinity of TRIM56.
K63-linked polyubiquitination of STING can be in a covalent
form, which is necessary for STING oligomerization and activa-
tion of downstream immune responses7. Like RIG-I, STING
could also be non-covalently modified with and activated by
unanchored polyubiquitin chains7,37. In this scenario, UBXN3B
could play a role by binding and bringing polyubiquitin chains to
STING, in light of recent findings that the UBA domain of some
UBXNs was able to bind polyubiquitin chains20. It is thus possible
that UBXN3B could also in part regulate STING ubiquitination
catalyzed by other E3 ligases indirectly.
In summary, we present physiological and biochemical evi-
dence that UBXN3B controls DNA virus infection by regulating
STING signaling. Our data offer an insight into the previously
unappreciated immune regulatory function of UBXN3B and
provide proof of methodology for investigating the physiological
functions of certain essential genes like UBXN3B in adult systemic
knockout animals.
Methods
Mouse models. Mice with the exon 1 of Ubxn3b flanked by two LoxP sites
(Ubxn3bflox/flox) were generated via homologous recombination by Dr. Fujimoto at
Nagoya University24. The homozygous Ubxn3bflox/flox were then crossed with
homozygous tamoxifen-inducible Cre recombinase-estrogen receptor T2 mice (The
Jackson Laboratory, Stock # 008463) to generate male and female Cre+/−
Ubxn3bflox littermates, which were mated to produce Cre+/−Ubxn3bflox/flox,
Ubxn3bflox/flox, Cre+/− for experimentation. Genotyping PCR was performed with
~40 ng genomic DNA and Choice Taq Blue Mastermix (Denville Scientific, Cat#
CB4065-8) under the following cycling conditions: 94 °C for 2 min (94 °C for 1
min, 60 °C for 30 s, 72 °C for 30 s) ×34 cycles, 72 °C for 7 min24. The primers for
LoxP were: forward primer, 5′-CCAACCTCTGTGGGTCCTC-3′ and reverse
primer, 5′-GCGATTGGGGATCTGAGTTA-3. This PCR reaction resulted in a
product of 187 bp (WT, LoxP negative) and/or 245 bp (mutant, LoxP positive). The
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primers for genotyping Cre were: common-5′AAGGGAGCTGCAGTGGAGTA-3′,
WT reverse, 5′-CCG AAA ATC TGTGGGAAGTC-3′, and mutant reverse, 5′-CG
GTTATTCAACTTGCACCA-3′. The PCR reaction resulted in a product of ~300
bp (WT, Cre negative) and/or 450 bp (mutant, Cre positive). To induce Ubxn3b
deletion, weaned mice were treated with 100 μl of tamoxifen (10 mg/ ml in corn oil)
(Sigma, #T5648) by intraperitoneal injection every 2 days for a total duration of
8 days26. The treated mice were housed for 1–2 weeks, allowing tamoxifen to be
metabolized completely (half-life ~16 h). The Sting-deficient strain (Stinggt/gt) was
initially developed by Dr. Russell Vance at the University of California, Berkeley38,
and is now available at the Jackson Laboratory (Stock # 017537). Sting−/− (null
knockout of exons 3–5) (Stock # 025805) and IFN-I receptor knockout (Ifnar1−/−)
(Stock # 028288) mice were also from the Jackson Laboratory. We used 8–10-week-
old sex-matched (both female and male) mice for all the experiments. All the
animal protocols were approved by the Institutional Animal Care and Use Com-
mittee at New York Medical College and Yale University adhering to the National
institutes of Health recommendations for the care and use of laboratory animals.
Reagents and antibodies. The rabbit anti-GAPDH (D16H11, Cat# 5174, 1:3000),
calreticulin (D3E6, Cat# 12238, 1:200 for IFA), α-Tubulin (Cat# 2144, 1:3000),
UBXN3B (D8H6D, Cat# 34945, 1:1000 for IB, 1:100 for IFA), TBK1 (D1B4, Cat#
3504, 1:1000), phospho-TBK1 (D52C2, Cat# 5483, 1:500), K63-linked poly-
ubiquitin (D7A11, Cat# 5621,1:500), phospho-IRF3 (4D4G, Cat# 4947, 1:500),
human phospho-STING (Cat# 85735, 1:500), and STING (D2P2F, Cat#13647,
1:500) were purchased from Cell Signaling Technology (Danvers, MA, USA). The
goat anti-TRIM56 (E-18, Cat# sc-249085, 1:200) was obtained from Santa Cruz
Biotechnology (CA, USA). The goat anti-UBXN3B was obtained from Genway
Biotech (Cat# GWB-5E6F34, 1:500, San Diego, CA, USA). The mouse anti-FLAG
(OTI4C5, Cat# TA50011, 1:2000), Myc (9E10, Cat# TA150121, 1:1000), and HA
(HA.C5, Cat# TA100012, 1:1000) were obtained from Origene (Rockville, MD,
USA). Lipofectamine 2000 was obtained from ThermoFisher (Waltham, MA,
USA). 2′3′-cGAMP (Cat# tlrl-nacga23), IFN stimulatory DNA derived from Lis-
teria monocytogenes genome (ISD, Cat# tlrl-isdn), polyI:C (1.5–8 kb, Cat# tlrl-pic),
FSL-1 (Pam2CGDPKHPKSF, Cat# tlrl-fsl), CpG DNA (5′-tcgtcgttttcggcgc:gcgccg-
3′, Cat# tlrl-2395), LPS (Cat# tlrl-pb5lps), and ssPolyU (Cat# tlrl-sspu) were
products of Invivogen (San Diego, CA, USA). The anti-FLAG M2 magnetic beads
(Clone M2, Cat# M8823) were from Sigma-Aldrich (St. Louis, MO, USA) and anti-
Myc magnetic beads (Clone 9E10, Cat# 88842) were from ThermoFisher (Wal-
tham, MA, USA). The mouse anti-human STING (Clone 723505, Cat# MAB7169,
1:200 for IFA) was available at R&D Systems (Minneapolis, MN, USA). Recom-
binant mouse IFN-α (Cat# 752802) was a product of BioLegend (San Diego, CA,
USA). The rabbit anti-HSV-1/HSV-2 serum, which is specific for the ICP’s and late
structural (virion) antigens, was purchased from Antibodies-online (Cat# ABIN
285517, 1:500).
Plasmid construction. FLAG-Myc-UBXN2A (Cat# MR203340, NCBI accession:
NM_145441) and FLAG-Myc-UBXN2B (Cat# MR204884, NCBI accession:
NM_026534) on pCMV6-entry vector were purchased from Origene (Rockville,
MD, USA). FLAG-UBXN1 was constructed by inserting the human UBXN1 open
reading frame (ORF) (NCBI accession: NM_015853.4) into pcDNA3-FLAG/Myc
vector39. The additional FLAG-UBXNs were a kind gift of Dr. Raymond J.
Deshaies at California Institute of Technology, USA20. HA-STING and FLAG-
STING-K150R were recently reported7,40. The truncated forms of human
UBXN3B, human AMFR, TRIM32, and TRIM56 were amplified by PCR, cut by
restriction enzymes, and inserted into pcDNA3-FLAG/Myc vector.
Cell culture and viruses. EMCV (Cat# VR129-B), SeV (Cantell strain,
Cat# VR-907), VSV (Indiana strain, Cat# VR-1238), and HSV-1 (Cat# VR1493)
were purchased from American Type Culture Collection (ATCC) (Manassas, VA,
USA) and the multiplicity of infection (MOI) was specified in each figure legend41.
Green fluorescent protein-tagged herpes simplex virus type I (KOS strain) was
provided by Dr. Rongtun Lin at the McGill University28. All viruses were propa-
gated in Vero cells.
HEK293T cells (Cat# CRL-3216), Vero cells (monkey kidney epithelial cells,
Cat# CCL-81), H1975 cells (human lung epithelial cells (Cat# CR5908), and L929
cells (mouse fibroblast cells, Cat# CCL-1) were purchased from ATCC (Manassas,
VA, USA). TLR4/MD2/CD14-expressing HEK293 cell line was obtained from
Invivogen (Cat# 293-htlr4md2cd14, San Diego, CA, USA). HEK293T/Vero cells
and L929/H1975 cells were grown in Dulbecco's modified Eagle's medium or
Roswell Park Memorial Institute (RPMI) 1640, respectively (Life Technologies,
Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) and
antibiotics/antimycotics. These cell lines are not listed in the database of commonly
misidentified cell lines maintained by ICLAC, and have not been authenticated in
our hands. They are routinely treated with MycoZAP (Lonza) and tested for
mycoplasma contamination in our hands.
Generation of HEK293T-STING cell line. Since HEK293T expresses a very low
level of STING, we thus constructed a FLAG-STING-expressing stable cell line.
The human STING ORF was subcloned into pcDNA3-FLAG vector, and then
transfected into HEK293T cells using Lipofectamine 2000. FLAG-STING-
expressing cells were selected with 200 µg/ml zeocin.
Ubxn3b deletion in primary MEFs. Pregnant Cre+/−Ubxn3bflox/flox females
(mated to Cre+/− Ubxn3bflox/flox male) were euthanized on day 14 of gestation.
Embryos were decapitated and eviscerated, and then digested with trypsin for 10
min at 37 °C rotating. Fibroblasts were filtered through a 100 μM filter, cultured in
RPMI 1640 medium (Life Technologies, NY, USA), supplemented with 10% FBS
and antibiotics/antimycotics, propagated for two passages, and then frozen41,42.
Cre+/− Ubxn3bflox/flox MEFs were identified by genotyping. The Cre+/−
Ubxn3bflox/flox MEFs were treated with 4-hydroxyl tamoxifen at 0.01 mg/ml for
3 days to generate Ubxn3b−/− cells. After induction, the cells were further passaged
two times in RPMI medium. Non-treated Cre+/− Ubxn3bflox/flox MEFs were
considered Ubxn3b+/+.
Differentiation of BMDMs and DCs. BMDMs were differentiated using a pub-
lished method43. Briefly, bone marrow cells were isolated from mock-pretreated
and tamoxifen-pretreated Cre+/− Ubxn3bflox/flox mice and then differentiated into
macrophages in L929-conditioned medium (RPMI 1640, 20% FBS, 30% L929
culture medium, 1× antibiotics/antimycotics) in 10-cm Petri dishes at 37 °C, 5%
CO2 for 5 days. The culture medium was replaced by fresh
L929-conditioned medium every 2 days. The attached BMDMs were dislodged by
pipetting and counted for plating in 12-well or 6-well cell culture plates. Bone
marrow-derived cDCs and pDCs were induced from bone marrow cells with
10 ng/ml murine GM-CSF and 100 ng/ml Flt3L (PeproTech), respectively, for
6–8 days44. BMDMs/DCs were cultured in RPMI 1640 medium containing 10%
(volume/volume (v/v)) FBS (Invitrogen, Carlsbad, CA, USA), 100 U/ml penicillin
and 100 μg/ml streptomycin (Invitrogen) and maintained at 37℃ and 5% CO2
overnight, and then washed once with pre-warmed fresh medium.
Isolation of human trophoblasts. Human trophoblasts were isolated from first
trimester or term placenta using published methods45,46. Briefly, a piece of placenta
was minced with a razor blade and then digested with 0.25% trypsin and 0.2 mg/ml
DNAse I in Hank’s balanced salt solution to release cells. The dispersed cells were
passed through a 40 µm cell strainer, and trophoblasts were isolated through
Percoll gradient (10–70% v/v) centrifugation. Cells were maintained in complete
RPMI 1640 medium with 10% FBS and antibiotics. The IRB of Yale University and
New York Medical College approved the study and deemed exemption of human
subject study47. The study used de-identified leftover specimens which were
otherwise discarded. The investigators did not have any contact with the subjects
and had no access to the patient information and did not link the results to the
subjects. The investigation was irrelevant to clinical care and uses random speci-
mens. The research did not investigate the health/disease status/genetic informa-
tion of the subjects.
Ligand treatment and viral infection conditions. PRR ligands were transfected
into cells with Lipofectamine 2000 using standard procedures. For hard-to-
transfect cells such as trophoblasts, H1975, MEFs, and DCs, transfection was
carried out in cell suspension. Briefly, cells were dislodged by trypsin digestion and
pelleted by brief centrifugation. The cell pellet was then suspended in the trans-
fection mix (DNA+ Lipofectamine 2000 prepared as above) for 20 min with
intermittent gentle agitation. Pre-warmed RPMI 1640 complete medium was then
added and plated for further culture. For viral infection, viruses were allowed to
attach and infect cells for 2 h; the cells were then washed with pre-warmed 1×
phosphate-buffered saline (PBS) once and incubated with fresh medium. The MOI
and infection time were specified for each experiment in the figure legend.
Generation of gene knockout cell lines with CRISPR-Cas9 technology. Two
target guide sequences (1-GGTCAGTGACCCGGCTGCGA, 2-
TACGTTCCCTGGTAGAAGAC common for both mouse and human UBXN3B)
were cloned into lentiCRISPRv2 vector and co-transfected into HEK293T cells with
the packaging plasmids pVSVg and psPAX248,49. The guide RNAs for human
STING were: 1-GGTGGAGCACCAGGTAC, 2-GGTACCGGAGAGTGTGCTC).
HEK293T-STING cells, trophoblasts, and H1975 cells were then transduced by
lentiviral particles. The WT control was lentiCRISPRv2 vector only. The trans-
duced cells were selected with puromycin at 1 µg/ml for trophoblasts, 1 µg/ml for
HEK293T cells and 0.5 µg/ml for H1975 cells. Successful knockout clones were
confirmed by immunoblotting.
Plaque-forming assay. Quantification of infectious viral particles in tissues/cell
culture supernatant was performed on Vero cell monolayer43,50. Briefly, 30–100 μg
(total proteins) of tissue lysates triturated in sterile PBS or serial dilutions of
supernatant was applied to confluent Vero cells (6-well plate) at 37 °C for 2 h. The
inoculum was then removed and replaced with 2 ml of DMEM complete medium
with 1% SeaPlaque agarose (Cat# 50100, Lonza). Plaques were visualized using
Neutral red (Sigma-Aldrich) after 3 days of incubation at 37 °C, 5% CO2.
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Mouse infection and disease monitoring. Six-week-old to eight-week-old
sex-matched littermates were infected with 1 × 107 plaque-forming units (PFUs) of
HSV-1/VSV intravenously or 200 PFU of EMCV intraperitoneally. Morbidity and
mortality was monitored twice a day. Neurological symptoms were assessed using
an arbitrary scoring criteria from 1 to 5 (where 1 indicated ruffled fur and hunched
posture but can easily be made to move around; 2 indicated a hunched posture and
slow to move; 3 indicated a hunched posture, some movement, and labored
breathing; 4 indicated a hunched posture, labored breathing, and little or no
movement; and 5 indicated moribund or dead)51
Reverse transcription and qPCR. A few grams of animal tissues, 25 µl of whole
blood, and up to 1 × 106 culture cells were collected in 350 µl of RLT buffer
(QIAGEN RNeasy Mini Kit). Soft tissues were homogenized using an electric pellet
pestle (Kimble Chase LLC, USA). RNA was extracted following the QIAGEN
RNeasy manufacturer’s instructions. Reverse transcription of RNA into com-
plementary DNA (cDNA) was performed using the BIO-RAD iScript™ cDNA
Synthesis Kit. Quantitative PCR (qPCR) was performed with gene-specific primers
and 6FAM–TAMRA (6-carboxyfluorescein–N,N,N,N-tetramethyl-6-carbox-
yrhodamine) probes or SYBR Green. Results were calculated using the –ΔΔCt
method and a housekeeping gene as an internal control. The qPCR primers and
probes for immune genes were reported in our previous studies42,52. The primer
pair for mouse Ubxn3b was 5′-GAGAAATATGGGAGGGCACA-3′ and 5′-AGAA
CAAGCCCAGAAAAGCA-3′. The primers for HSV-1 were: 5′-AGCCTGTACC
CCAGCATCAT-3′ and 5′-ACCTCGATCTCCAGGTAGTCC-3′. The Taqman
gene expression assays for Ifit1 (Mm00515153_m1), Oas1a (Mm00836412_m1),
Isg15 (Mm01705338_s1), IFNB1 (Hs01077958_s1), and TNFA (Hs00174128_m1)
were obtained from ThermoFisher Scientific. The housekeeping gene controls were
beta actin (ACTB), peptidylprolyl isomerase A (PPIA), and hydroxymethylbilane
synthase (HMBS). A previous study demonstrated that HMBS was the least
unaffected housekeeping gene during HSV-1 infection; PPIA was most stable for
other viral infections53. Human HMBS primers are: 5′-ACGGCTCAGATAGCA
TACAAGAG-3′ and 5′-GTTACGAGCAGTGATGCCTACC-3′; mouse Hmbs:
5′-GTGCCTACCATACTACCTCCTG-3′ and 5′-ACTCTCCTCAGAGAGCTGGT
TC-3′; human PPIA: 5′-GGCAAATGCTGGACCCAACACA-3′ and 5′-TGCTGG
TCTTGCCATTCCTGGA-3′; mouse Ppia: 5′-CATACAGGTCCTGGCATCTTG
TC-3′ and 5′-AGACCACATGCTTGCCATCCAG-3′. These primer sequences
were available at Origene Technologies (Rockville, MD, USA).
ELISA. A commercial ELISA (enzyme-linked immunosorbent assay) Kit was used
to measure the levels of IFN-α (Cat# 42120) and IFN-β (Cat# 42400, PBL Assay
Sciences, Piscataway Township, NJ, USA) proteins in either cell culture super-
natants or mouse sera.
Immunoblotting. Standard sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis, Western blotting, and an enhanced chemiluminescent (ECL) substrate
(ThermoFisher, Cat# 32106) was applied except for STING dimerization assay
where no reducing agent was applied to the samples. In some cases, such as
K63-Ub, an ultra-sensitive ECL substrate for low-femtogram-level detection
(ThermoFisher, Cat# 34095) was used.
Co-immunoprecipitation. HEK293T cells were transfected with expression plas-
mids using Lipofectamine 2000. Whole-cell extracts were prepared from trans-
fected cells in lysis buffer (150 mM NaCl, 50 mM Tris, pH 7.5, 1 mM EDTA, 0.5%
NP40, 10% glycerol) and were incubated with 50 µl of anti-FLAG magnetic beads
for 2 h at 4 °C. Co-immunoprecipitation was performed according to the manu-
facturer’s instructions (anti-Flag magnetic beads, Sigma-Aldrich)
Co-immunoprecipitation of endogenous proteins. A total of 1 × 107 cells were
lysed in 2 ml of lysis buffer (150 mM NaCl, 50 mM Tris, pH 7.5, 1 mM EDTA, 0.5%
NP40, 10% glycerol, protease inhibitor cocktail). Lysates were cleared by cen-
trifugation at 6000 × g for 10 min at 4 °C. For UBXN3B trans-complementation,
MEFs were transfected with 5 µg vector or FLAG-UBXN3B per 1 × 106 cells,
respectively, by electroporation (Lonza, Cat# DCR1003) 20 h before HSV-1
infection. Two micrograms of rabbit IgG or 50 µl of anti-STING/per sample (Cell
Signaling Technology, Cat# 13647) was cross-linked to 50 µl of protein A/G
agarose beads (ThermoFisher, Cat# 20421) with dimethyl pimelimidate (Ther-
moFisher, Cat# 21666). The cleared lysates were incubated with the agarose beads
with gentle agitation at 4 °C overnight. The beads were washed five times in ice-
cold wash buffer (150 mM NaCl, 50 mM Tris, pH 7.5, 1 mM EDTA, 0.5% NP40),
and bound proteins were eluted by boiling for 3 min in SDS sample lysis buffer.
Dual luciferase reporter assays. Seventy percent confluent HEK293T cells were
transfected with 50 ng of pRL-TK reporter (herpes simplex virus thymidine kinase
promoter-driven renilla luciferase; internal control), 100 ng of pGL3-ISRE luci-
ferase reporter (firefly luciferase; experimental reporter) plasmid, and other
expressing plasmids as appropriate. Twenty-four hours after transfection, luciferase
activity was measured using a Promega Dual Glow Kit (Cat# E2980) according to
the manufacturer’s instructions.
Immunofluorescent microscopy. Cells were fixed with 4% paraformaldehyde. The
cells were sequentially permeabilized with 0.5% Triton X-100, blocked with 2%
goat serum, incubated with primary antibody (rabbit anti-UBXN3B, 1:100, Cell
Signaling (Cat# 34945, Clone D8H6D); mouse anti-STING, 1:100, R&D Systems
(Clone 723505, Cat# MAB7169); and rabbit anti-calreticulin, 1:200, Cell Signaling
(Clone D3E6, Cat# 12238)) at 4 °C overnight, washed briefly, and then incubated
with Alexa Fluor 488/594-conjugated goat anti-rabbit/mouse IgGs (1:200, Life
Technologies, Cat# A11070) for 1 h at room temperature. Nuclei were counter-
stained with DAPI (4',6-diamidino-2-phenylindole). Images were acquired using a
Zeiss Axiovert-200 fluorescence microscope (objective, ×40).
Graphing and statistics. The sample size chosen for our animal experiments in
this study was estimated based on our prior experience of performing similar sets
of experiments and power analysis calculations (http://isogenic.info/html/
power_analysis.html). All animal results were included and no method of rando-
mization was applied. For all the bar graphs, data were expressed as mean ± s.e.m.
Prism 7 software (GraphPad Software) was used for survival curves, charts, and
statistical analyses. Survival curves were analyzed using a log-rank (Mantel–Cox)
test. For in vitro results, a standard two-tailed unpaired Student’s t test was used.
For animal studies, an unpaired two-tailed non-parametric/parametric
Mann–Whitney U test was applied to statistical analysis. P values ≤0.05 were
considered significant. The sample sizes (biological replicates), specific statistical
tests used, and the main effects of our statistical analyses for each experiment were
detailed in each figure legend.
Data availability. The datasets generated during and/or analyzed during the
current study are available from the corresponding author upon request.
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